4ANYTHING.business helps business professionals find products, services, news, and practical guidance faster. We combine multiple search indexes, curated sources, and AI tools to surface relevant, actionable results that general search often buries. Use filters for industry, region, company size, and data type to narrow results and save time. Part of the 4SEARCH network of topic specific search engines.
WASHINGTON (AP) — The U.S.-Ukraine alliance is careening toward a possible breaking point, with Moscow strengthened by President Donald Trump’s recent rejection of new Russia sanctions and Kyiv...
William Blair analyst Alethia Young initiated coverage of Cytokinetics (CYTK) with an Outperform rating. Cytokinetics is a commercial-stage spe... Cytokinetics initiated with an Outperform at William Blair William Blair analyst Alethia Young initiated coverage of Cytokinetics (CYTK) with an Outperform…
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cytokinetics (CYTK), Roche Holding AG (RHHVF) and Arrowhead Pharmaceuticals (ARWR) with bullish sentiments. In a report released yesterday, Leonid Timashev from RBC Capital…
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rhythm Pharmaceuticals (RYTM), Arcus Biosciences (RCUS) and Cytokinetics (CYTK) with bullish sentiments. In a report released today, Seamus Fernandez from Guggenheim reiterated a…
The West Australian is a leading news source in Perth and WA. Breaking local and world news from sport and business to lifestyle and current affairs.
Shares of Disc Medicine Inc. (IRON) gained over 40% on Monday morning after the company announced positive topline results from its Phase 3 APOLLO trial of bitopertin in adults and adolescents with erythropoietic protoporphyria (EPP), including X-linked protoporphyria. Disc Medicine Shares Surge…
Disc Medicine (IRON) said Monday its experimental therapy, bitopertin, met all primary and secondary endpoints in the phase 3 trial in patients with erythropoietic protoporphyria... Oops, something went wrong Disc Medicine Says Metabolic Disorder Drug Meets Main Goal in Phase 3 Trial;…
America's power problem shows up in Genia Weitz's mailbox as a $1,340 electric bill she has nine days to pay—more than she brings in a month. Writing for the New... As US' Hottest Summer Cools, Many Face Staggering Power Bills…
All amounts in US dollars unless otherwise stated. This third tranche payment brings RE Royalties' total investment in royalties over Solaris' portfolio to US$4.8 million. The Company previously funded US$3 million, as announced on January 7, 2026, followed by US$800,000 as announced…
All amounts in US dollars unless otherwise stated. Singapore Solar is a renewable energy developer focused on utility-scale and commercial and industrial scale solar, wind and battery energy storage projects in Southeast Asia, with a current focus on the Philippines.